---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-021534"
form_type: "8-K"
ticker: "OFIX"
cik: "0000884624"
company_name: "Orthofix Medical Inc."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:55:51.945098+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Orthofix Q3: net sales $114M, GAAP EPS ($0.53); FY22 adj. EBITDA guidance cut; SeaSpine merger

## Summary
- Net sales $114.0M, up 1% reported, 5% constant currency; Global Orthopedics grew 19% constant currency.
- GAAP EPS ($0.53) vs ($0.11) prior year; adjusted EPS $0.13 vs $0.10.
- Net loss widened to $10.7M from $2.2M; adjusted net income $2.7M.
- FY2022 guidance lowered: net sales $457-463M, adjusted EBITDA $52-54M (from $53-57M), adjusted EPS $0.40-0.50 (from $0.45-0.55).
- Announced agreement to merge with SeaSpine in all-stock merger of equals on October 11, 2022.

## SEC filing metadata
- accession: 0000950170-22-021534
- form_type: 8-K
- ticker: OFIX
- cik: 0000884624
- company_name: Orthofix Medical Inc.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/884624/000095017022021534/0000950170-22-021534-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/884624/000095017022021534/ofix-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-021534
- JSON: https://secwatch.observer/filing/0000950170-22-021534.json
- Plain text: https://secwatch.observer/filing/0000950170-22-021534.txt

## Key facts
- Earnings Releases
  Orthofix Medical Inc. reported third quarter ended September 30, 2022 results: revenue $114.0 million, net income Net loss was $(10.7) million, EPS $(0.53) per share. Guidance reaffirmed.
  - Period: third quarter ended September 30, 2022
  - Revenue: $114.0 million
  - Net income: Net loss was $(10.7) million
  - EPS: $(0.53) per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Orthofix Reports Third Quarter 2022 Results • Net sales of $114.0 million, an increase of 1% on a reported basis and 5% on a constant currency basis over prior year • Global Orthopedics net sales growth of 19% on a constant currency basis driven by new product and channel investments • GAAP EPS of ($0.53) and adjusted EPS of $0.13
  evidence_url: https://www.sec.gov/Archives/edgar/data/884624/000095017022021534/0000950170-22-021534-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.